In Brief
Refine Search
Pharmaceutical
Spain’s largest drugmaker Almirall says it has received approval from the European Commission for Klisyri (tirbanibulin) for the topical treatment of actinic keratosis (AK) on the face or scalp in adults. 21 July 2021
Biotechnology
Japanese drugmaker Kyowa Kirin says that its Crysvita (burosumab) has been approved for the option of self-administration in the European Union (EU) for the treatment of X-linked hypophosphatemia (XLH), a rare metabolic bone disease that impacts children and adults. 20 July 2021
Biotechnology
Chicago-based specialty drug company Xeris Pharmaceuticals has agreed a deal with Tetris Pharma for the commercialization of Ogluo (glucagon) in Europe. 20 July 2021
Pharmaceutical
The government of China’s Jiangsu province added six rare disease drugs into its local medicines reimbursement list (LDRL). 20 July 2021
Pharmaceutical
Portuguese drugmaker BIAL and Slovenia-based Medis Pharmaceutical Company have entered into an exclusive partnership on two central nervous system drugs. 19 July 2021
Pharmaceutical
The world's first Covid-19 human challenge study is to be expanded. 15 July 2021
Pharmaceutical
Germany’s Merck KGaA has entered into a contract manufacturing agreement with Universal Corporation, Kenya, a subsidiary of India’s Strides Pharma Science, for the large-scale production of a new pediatric medication, once it has been registered. 15 July 2021
Biotechnology
The Centers for Medicare and Medicaid Services (CMS) has begun the formal process to determine whether and to what extent Aduhelm (aducanumab) will be covered through Medicare. 13 July 2021
Pharmaceutical
Global law firm Hogan Lovells said today it has secured an important victory before the Commercial Court of London, UK, for its client Acerus, a Canadian-based specialty pharmaceuticals company, against Recipharm Limited. 12 July 2021
Biotechnology
Vor Biopharma, a cell therapy company pioneering engineered hematopoietic stem cell (eHSC) therapies combined with targeted therapies for the treatment of cancer, today announced a collaboration with Janssen Biotech, a unit of US healthcare giant Johnson & Johnson. 9 July 2021
Biotechnology
US biotech Daré Bioscience revealed in a stock exchange filing yesterday that it has entered into an agreement with the Bill & Melinda Gates Foundation, under which it was awarded a new grant of up to $48.95 million to support the development of DARE-LARC1, the company’s investigational user-controlled, long-acting reversible contraceptive. 8 July 2021
article
The World Health Organization (WHO) has added “lifesaving” interleukin-6 receptor blockers to its list of treatments for COVID-19, only the second drugs to be recommended as effective against the disease – as the pandemic continues to accelerate across the world. 7 July 2021
Pharmaceutical
French ophthalmology company Nicox’ shares edged up 1.5% to 3.85 euros today, after it announced that it has amended its March 2019 license agreement with China’s Ocumension Therapeutics, under which the latter has exclusive rights to develop and commercialize Zerviate (cetirizine ophthalmic solution), 0.24% in the Chinese and the majority of South East Asian markets. 5 July 2021
Biotechnology
Cambridge, UK-based Transine Therapeutics has appointed Jan Thirkettle as chief executive. Dr Thirkettle was formerly chief development officer at Freeline Therapeutics, overseeing a novel AAV manufacturing platform. 5 July 2021
Pharmaceutical
USA-headquartered clinical research organization (CRO) Parexel, focused on development and delivery of innovative new therapies to advance patient health, has announced the execution of a definitive merger agreement under which it will be acquired by Sweden’s EQT IX fund and the private equity business within Goldman Sachs Asset Management from Pamplona Capital Management for $8.5 billion. 3 July 2021
Biotechnology
The European Medicine Agency’s committee for human medicines CHMP has approved a scale-up of the active substance manufacturing process at Janssen Biologics BV. 3 July 2021
Biotechnology
Recently established Swiss start-up MoonLake Immunotherapeutics today announced key leadership appointments. 1 July 2021
Biotechnology
China-based drugmaker Hutchmed has announced the closure of its global offering and primary listing in Hong Kong. 30 June 2021
Pharmaceutical
German specialty pharma company Paion has picked up UK approval for Byfavo (remimazolam besylate) as an option for procedural sedation. 30 June 2021
Pharmaceutical
Swiss firm Urovant Sciences and USA-based Sunovion Pharmaceuticals, a subsidiary of Japan’s Sumitomo Dainippon, have launched Gemtesa (vibegron) in the USA. 30 June 2021
Biotechnology
Japanese drugmaker Takeda has launched Fruzaqla (fruquintinib) in its home country. 22 November 2024
Biotechnology
Chinese biopharma CStone Pharmaceuticals has announced a strategic commercial collaboration with Pharmalink Store, a prominent pharmaceutical company based in the United Arab Emirates (UAE). 22 November 2024
Biotechnology
Zhongshan-based biopharma company Akeso will await the verdict of the Chinese medicines regulator on a penpulimab-based combo therapy. 22 November 2024
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Pharmaceutical
Shanghai-based Zai Lab and New York’s Pfizer are to work together on the commercialization of Xacduro (sulbactam-durlobactam) in China. 22 November 2024
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
British pharma major AstraZeneca is facing challenges in its bid to secure full approval for its anticoagulant reversal therapy, Andexxa (andexanet alfa), in the USA. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
Privately-held US biotech Alloy Therapeutics has announced a strategic collaboration and license agreement with Takeda Pharmaceutical. 21 November 2024
Pharmaceutical
Japanese drugmaker Eisai has announced that the amyotrophic lateral sclerosis (ALS) treatment Rozebalamin for Injection (mecobalamin) has been launched in Japan as a treatment for slowing progression of functional impairment in amyotrophic lateral sclerosis. 21 November 2024
Pharmaceutical
Germany's Merck has spent more than 25 years researching and developing solutions for advancing multiple sclerosis (MS) care. 21 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Pharmaceutical
Swiss pharma giant Novartis today announced an upgrade to its mid-term guidance, in advance of its Meet Novartis Management event for investors and analysts in London. 21 November 2024
Biotechnology
The US Food and Drug Administration (FDA) has granted accelerated approval of Ziihera (zanidatamab-hrii) 50mg/mL for injection for intravenous use, say the drug’s developer, Jazz Pharmaceuticals. 21 November 2024
Biotechnology
Eli Lilly is not resting on its laurels when it comes to the fast-growing field of obesity treatments, an area in which it is already a leader. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
Biotechnology
Astellas Pharma has been hit by bad news from the US Food and Drug Administration, which will not currently approve the firm’s request to supplement the label for Izervay (avacincaptad pegol). 21 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze